Ultra Seal Triple Antibiotic
NDC Package 42213-360-28

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ultra Seal Triple Antibiotic is a . Marketed by Ultra Seal Corporation, this product is identified by NDC 42213-360 and is authorized under FDA application part333B.

Identification & Billing

NDC Package Code
42213-360-28
Package Description
1 TUBE in 1 CARTON / 28 g in 1 TUBE
Product Code
11-Digit Billing Format
42213036028

Clinical Specifications

Proprietary Name
Ultra Seal Triple Antibiotic
Dosage Form
-

Regulatory & Marketing

Labeler Name
Ultra Seal Corporation
FDA Application #
part333B
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
04-12-2011
End Marketing Date
01-01-2022
Listing Expiration
01-01-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (42213-360). Click a package code to view its specific billing and regulatory data.

144 PACKET in 1 BOX / .9 g in 1 PACKET (42213-360-09)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42213-360-28 identifies a specific commercial package of 1 tube in 1 carton / 28 g in 1 tube of Ultra Seal Triple Antibiotic, labeled by Ultra Seal Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ultra Seal Corporation on April 12, 2011. The current certification is valid through January 01, 2022.

How is this Ultra Seal Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42213036028. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42213-360-28
11-Digit CMS (5-4-2)
42213-0360-28

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.